ArticleProceedings of the National Academy of Sciences of the United States of America2022

Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages.

Mariko Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.